Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology
- PMID: 36943925
- PMCID: PMC12019885
- DOI: 10.1161/CIR.0000000000001122
Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology
Abstract
Heart failure with preserved ejection fraction (HFpEF) is one of the most common forms of heart failure; its prevalence is increasing, and outcomes are worsening. Affected patients often experience severe exertional dyspnea and debilitating fatigue, as well as poor quality of life, frequent hospitalizations, and a high mortality rate. Until recently, most pharmacological intervention trials for HFpEF yielded neutral primary outcomes. In contrast, trials of exercise-based interventions have consistently demonstrated large, significant, clinically meaningful improvements in symptoms, objectively determined exercise capacity, and usually quality of life. This success may be attributed, at least in part, to the pleiotropic effects of exercise, which may favorably affect the full range of abnormalities-peripheral vascular, skeletal muscle, and cardiovascular-that contribute to exercise intolerance in HFpEF. Accordingly, this scientific statement critically examines the currently available literature on the effects of exercise-based therapies for chronic stable HFpEF, potential mechanisms for improvement of exercise capacity and symptoms, and how these data compare with exercise therapy for other cardiovascular conditions. Specifically, data reviewed herein demonstrate a comparable or larger magnitude of improvement in exercise capacity from supervised exercise training in patients with chronic HFpEF compared with those with heart failure with reduced ejection fraction, although Medicare reimbursement is available only for the latter group. Finally, critical gaps in implementation of exercise-based therapies for patients with HFpEF, including exercise setting, training modalities, combinations with other strategies such as diet and medications, long-term adherence, incorporation of innovative and more accessible delivery methods, and management of recently hospitalized patients are highlighted to provide guidance for future research.
Keywords: AHA Scientific Statements; aged; cardiac rehabilitation; exercise therapy; exercise tolerance; heart failure.
Conflict of interest statement
The American Heart Association and the American College of Cardiology make every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
Figures


Similar articles
-
Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.J Am Coll Cardiol. 2023 Apr 18;81(15):1524-1542. doi: 10.1016/j.jacc.2023.02.012. Epub 2023 Mar 21. J Am Coll Cardiol. 2023. PMID: 36958952 Free PMC article.
-
Differential Clinical Profiles, Exercise Responses, and Outcomes Associated With Existing HFpEF Definitions.Circulation. 2019 Jul 30;140(5):353-365. doi: 10.1161/CIRCULATIONAHA.118.039136. Epub 2019 May 28. Circulation. 2019. PMID: 31132875 Free PMC article.
-
Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.Eur J Heart Fail. 2022 Aug;24(8):1327-1345. doi: 10.1002/ejhf.2601. Epub 2022 Jul 31. Eur J Heart Fail. 2022. PMID: 35775383 Free PMC article.
-
Pathophysiology of Exercise Intolerance and Its Treatment With Exercise-Based Cardiac Rehabilitation in Heart Failure With Preserved Ejection Fraction.J Cardiopulm Rehabil Prev. 2020 Jan;40(1):9-16. doi: 10.1097/HCR.0000000000000481. J Cardiopulm Rehabil Prev. 2020. PMID: 31764536 Free PMC article. Review.
-
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction.Heart Fail Clin. 2021 Jul;17(3):397-413. doi: 10.1016/j.hfc.2021.03.004. Heart Fail Clin. 2021. PMID: 34051972 Review.
Cited by
-
Systems of care for ambulatory management of decompensated heart failure.Front Cardiovasc Med. 2024 Feb 21;11:1350846. doi: 10.3389/fcvm.2024.1350846. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38455722 Free PMC article. Review.
-
Temporal Trends in Heart Failure Management and Outcomes: Insights From a Japanese Multicenter Registry of Tertiary Care Centers.J Am Heart Assoc. 2023 Nov 7;12(21):e031179. doi: 10.1161/JAHA.123.031179. Epub 2023 Nov 6. J Am Heart Assoc. 2023. PMID: 37929712 Free PMC article.
-
From Hospital to Home: Evidence-Based Care for Worsening Heart Failure.JACC Adv. 2024 Jul 31;3(9):101131. doi: 10.1016/j.jacadv.2024.101131. eCollection 2024 Sep. JACC Adv. 2024. PMID: 39184855 Free PMC article. Review.
-
Comparing Glucagon-Like Peptide-1 Receptor Agonists to Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure With Preserved Ejection Fraction: A Systematic Review.Cureus. 2025 Feb 5;17(2):e78570. doi: 10.7759/cureus.78570. eCollection 2025 Feb. Cureus. 2025. PMID: 40062142 Free PMC article. Review.
-
Heart failure with preserved ejection fraction.Nat Rev Dis Primers. 2024 Aug 14;10(1):55. doi: 10.1038/s41572-024-00540-y. Nat Rev Dis Primers. 2024. PMID: 39143132 Review.
References
-
- Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, Anker SD, Atherton J, Bohm M, Butler J, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021;27:P387–P413. doi: 10.1016/j.cardfail.2021.01.022 - DOI - PubMed
-
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published corrections appear in Circulation. 2022;145:e1033 and Circulation. 2022;146:e185]. Circulation. 2022;145:e895–e1032. doi: 10.1161/CIR.0000000000001063 - DOI - PubMed
-
- Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical